Sentence examples for fraudulent labels from inspiring English sources

The last one I remember was "a Warby Parker for mattresses," which struck a chord with so many who have suffered at the crony hands of mattress dealers and fraudulent labels.

The farm-to-table backlash is driven by accusations of fraudulent labels and deceitful advertising.

He said he worried that the ruckus over fraudulent labeling "sends a bad signal to customers and casts a shadow over all meat producers".

— Maria Newman The Economist: The never-ending battle between government agencies and private certifying bodies in regulating the fraudulent labeling of both kosher and halal food is heating up.

"Patronising, unscientific nonsense" from a finger-wagging government that likes to harass consumers on food and health but fails to address the real villains: Big Sugar, fraudulent labelling, monopolising retailers.

But he added in an e-mail statement: "Restoring the trust and confidence of European consumers and trading partners in our food chain following this fraudulent labeling scandal is now of vital importance for the European economy, given that the food sector is the largest single economic sector" in the European Union.

Another department microbiologist, Gerald Zirnstein, called the processed beef "pink slime" in a 2002 e-mail message to colleagues and said, "I do not consider the stuff to be ground beef, and I consider allowing it in ground beef to be a form of fraudulent labeling".

Expensive herbs like ginseng are always a possible target for fraudulent labeling.

"Restoring the trust and confidence of European consumers and trading partners in our food chain following this fraudulent labelling scandal is now of vital importance for the European economy," said EU Commissioner for Health and Consumers Tonio Borg.

In a 2002 email to colleagues, one of these scientists wrote: "I do not consider the stuff to be ground beef, and I consider allowing it in ground beef to be a form of fraudulent labeling".

Through a series of rulings from 2011 to 2013, the U.S. Supreme Court exempted generic drug makers from state-law liability for both design-defect based damages and for inadequate or fraudulent labeling.